All this by June 30 2016...IMPRESSIVE!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

1. Start of Kevetrin advanced study in ovarian cancer.
2. Start of Brilacidin ABSSSI Phase 3
3. Start of Brilacidin for Ulcerative Proctitis proof of concept trial
(phase 2)
4. Top line data on Kevetrin Phase 1 trial for advanced solid tumors
5. Top line data on Prurisol Phase 2 trial for chronic plaque psoriasis
6. Interim analysis for Brilacidin Phase 2 trial for Oral Mucositis
7. Start of Retinoblastoma program, formulation and toxicity studies
8. Additional ototoxicity studies with Brilacidin in different
concentrations
9. Gram- negative and anti-fungal progress
10. Submission of grant application for study of Kevetrin in Pancreatic
cancer with renowned hospital.